2-105080028-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_182640.3(MRPS9):āc.455A>Gā(p.Tyr152Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,459,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_182640.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPS9 | NM_182640.3 | c.455A>G | p.Tyr152Cys | missense_variant | 5/11 | ENST00000258455.8 | NP_872578.1 | |
MRPS9 | XM_011511644.3 | c.83A>G | p.Tyr28Cys | missense_variant | 4/10 | XP_011509946.1 | ||
MRPS9 | XM_047445533.1 | c.455A>G | p.Tyr152Cys | missense_variant | 5/7 | XP_047301489.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPS9 | ENST00000258455.8 | c.455A>G | p.Tyr152Cys | missense_variant | 5/11 | 1 | NM_182640.3 | ENSP00000258455.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249780Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135056
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1459198Hom.: 0 Cov.: 29 AF XY: 0.0000138 AC XY: 10AN XY: 725998
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2024 | The c.455A>G (p.Y152C) alteration is located in exon 5 (coding exon 5) of the MRPS9 gene. This alteration results from a A to G substitution at nucleotide position 455, causing the tyrosine (Y) at amino acid position 152 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at